217 related articles for article (PubMed ID: 30054103)
1. Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis.
Matsuo K; Blake EA; Machida H; Mandelbaum RS; Roman LD; Wright JD
Gynecol Oncol; 2018 Sep; 150(3):501-508. PubMed ID: 30054103
[TBL] [Abstract][Full Text] [Related]
2. The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
Lindquist S; Frederiksen K; Petersen LK; Kjær SK
Int J Cancer; 2024 Jul; 155(1):61-70. PubMed ID: 38418719
[TBL] [Abstract][Full Text] [Related]
3. Incidence of ano-genital and head and neck malignancies in women with a previous diagnosis of cervical intraepithelial neoplasia.
Gaudet M; Hamm J; Aquino-Parsons C
Gynecol Oncol; 2014 Sep; 134(3):523-6. PubMed ID: 25042671
[TBL] [Abstract][Full Text] [Related]
4. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H
Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437
[TBL] [Abstract][Full Text] [Related]
6. Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study.
Bertoli HK; Thomsen LT; Iftner T; Dehlendorff C; Kjær SK
Gynecol Oncol; 2020 May; 157(2):456-462. PubMed ID: 32008794
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Risk for Noncervical Anogenital Cancer in Women with Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study.
Sand FL; Munk C; Jensen SM; Svahn MF; Frederiksen K; Kjær SK
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1090-7. PubMed ID: 27358257
[TBL] [Abstract][Full Text] [Related]
8. Five-year relative survival for human papillomavirus-associated cancer sites.
Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R
Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738
[TBL] [Abstract][Full Text] [Related]
9. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
10. Second primary anal and oropharyngeal cancers in cervical cancer survivors.
Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S
Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108
[TBL] [Abstract][Full Text] [Related]
11. Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
Saleem AM; Paulus JK; Shapter AP; Baxter NN; Roberts PL; Ricciardi R
Obstet Gynecol; 2011 Mar; 117(3):643-649. PubMed ID: 21343768
[TBL] [Abstract][Full Text] [Related]
12. Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer.
Matsuo K; Machida H; Horowitz MP; Shahzad MMK; Guntupalli SR; Roman LD; Wright JD
Am J Obstet Gynecol; 2017 Nov; 217(5):580.e1-580.e10. PubMed ID: 28666700
[TBL] [Abstract][Full Text] [Related]
13. Subsequent malignancies associated with carcinoma of the uterine cervix: including an analysis of the effect of patient and treatment parameters on incidence and sites of metachronous malignancies.
Kapp DS; Fischer D; Grady KJ; Schwartz PE
Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):197-205. PubMed ID: 7085375
[TBL] [Abstract][Full Text] [Related]
14. Risk of human papillomavirus-associated cancers among persons with AIDS.
Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
[TBL] [Abstract][Full Text] [Related]
15. Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark.
Olsen J; Jørgensen TR; Kofoed K; Larsen HK
BMC Public Health; 2012 Dec; 12():1082. PubMed ID: 23244352
[TBL] [Abstract][Full Text] [Related]
16. Update of HPV-associated female genital cancers in the United States, 1999-2004.
Watson M; Saraiya M; Wu X
J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
[TBL] [Abstract][Full Text] [Related]
17. Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected Hispanics living in the United States.
Ortiz AP; Engels EA; Nogueras-González GM; Colón-López V; Soto-Salgado M; Vargas A; Machin M; Shiels MS
Cancer; 2018 Dec; 124(23):4520-4528. PubMed ID: 30345506
[TBL] [Abstract][Full Text] [Related]
18. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of patients with multiple potentially human papillomavirus-related malignancies.
Skinner HD; Sturgis EM; Klopp AH; Ang KK; Rosenthal DI; Garden AS; Morrison WH; Gunn GB; Beadle BM
Head Neck; 2014 Jun; 36(6):819-25. PubMed ID: 23720126
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
Gilbert DC; Wakeham K; Langley RE; Vale CL
Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]